Continuous administration of GLP-1 to T2D patients restores GSIS and normalizes glycemia [12], and stable analogs of GLP-1 (avoiding rapid degradation by DPP-4] are currently among the best available treatments of T2D. Here, GCG is linked to type 2 diabetes mellitus.